CD109 and urothelial carcinoma: Although it is reported that CD109 is preferentially expressed in the early stage of tumorigenesis in oral tumor and urothelial carcinomas [43,46], we demonstrated that high expression of CD109 was significantly associated with advanced stage in STSs.